Rapid Screening for Elemental Impurities using ICP-MS

News
Article
Pharmaceutical TechnologyPharmaceutical Technology-11-15-2014
Volume 2014 eBook
Issue 3

The authors describe a rapid, single-point calibration approach for ICP–MS analysis of raw materials used in drug product manufacturing.

 

The official implementation of United States Pharmacopeia (USP) <232> will require measurement of elemental impurities using inductively coupled plasma–mass spectrometry (ICP–MS). The authors describe a rapid, single-point calibration approach for ICP–MS analysis of raw materials used in drug product manufacturing.

 

Download Pharmaceutical Technology’s

2014 Analytical and Bioanalytical Testing eBook

.



 

Articles in this issue
PTebook1114_Viral_185.jpg
The Challenge of Finding the Unknown
PTebook1114_MethodTransfer_185.jpg
Keys to Successful Method Transfer
PTebook1114__AQbD185.jpg
AQbD Adds Rigor to Method Development
PTebook1114_SGS_185.jpg
Validation of a Multiplex Bead-Based Assay
PTebook1114_PerkinElmer_185.jpg
Rapid Screening for Elemental Impurities using ICP-MS
PTebook1114_Allotrope_185.jpg
Standardizing Data Management
PTebook1114_0Products.jpg
Advances in Analytical Technology
Recent Videos
US tariff rate rising , trade policy , business graph and dollars banknote , tax calculation change | Image Credit: © janews094 - stock.adobe.com
Drug Digest: Strategic Partnerships
Related Content
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

New CDMO Meribel Pharma Solutions Launches with 13 Sites in Europe

Patrick Lavery
April 16th 2025
Article

The new United Kingdom-based firm has sites located in France, Spain, and Sweden, thanks to an acquisition of Synerlab Group and several Recipharm facilities in 2024.

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol
April 30th 2024
Podcast

In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

Bayer Announces FDA’s First Full Approval of NTRK Inhibitor

Patrick Lavery
April 14th 2025
Article

Vitrakvi (larotrectinib) was first granted accelerated approval by FDA in November 2018.

Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development

Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development

March 26th 2024
Podcast

In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.

TOP NEWS on grunge world map | Image Credit: © Sean K - stock.adobe.com

Agentic AI Growth Predicted, but More Than Half of Pharma Still Resisting Change: Report

Patrick Lavery
April 8th 2025
Article

Lack of skills in the AI realm was a distant second among those surveyed about the biggest barrier to innovation while using the technology.

Blue Paper Boat Leading A Fleet Of Small White Boats With Compass Icon On Grey Concrete - Leadership Concept | Image Credit: ©Philip Steury -stock.adobe.com

Navigating the Complexities of Emerging Therapy Development

Cynthia A. Challener
April 8th 2025
Article

Advancement of emerging therapies faces hurdles across all aspects and phases of drug development and manufacturing.